SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-015277
Filing Date
2021-11-09
Accepted
2021-11-09 16:05:29
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K azyo-20211109x8k.htm   iXBRL 8-K 40815
2 EX-99.1 azyo-20211109xex99d1.htm EX-99.1 154389
3 GRAPHIC azyo-20211109xex99d1001.jpg GRAPHIC 28873
  Complete submission text file 0001558370-21-015277.txt   372970

Data Files

Seq Description Document Type Size
4 EX-101.SCH azyo-20211109.xsd EX-101.SCH 3025
5 EX-101.LAB azyo-20211109_lab.xml EX-101.LAB 16735
6 EX-101.PRE azyo-20211109_pre.xml EX-101.PRE 10605
7 EXTRACTED XBRL INSTANCE DOCUMENT azyo-20211109x8k_htm.xml XML 5066
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 211392039
SIC: 2836 Biological Products, (No Diagnostic Substances)